Peptide Characterization

Introduction: Disulfide Bond Mapping of Cyclic Peptides is one of the most technically demanding — and most heavily scrutinized — […]

Introduction: Why Demonstrating Peptide Sameness Is Analytically Challenging Establishing “sameness” for a traditional small-molecule generic drug generally involves confirming chemical

Introduction: When you decide to outsource peptide characterization, the quality of your results depends less on which CRO you choose

The modern pharmaceutical landscape is experiencing a significant transformation, moving beyond traditional low-molecular-weight compounds toward larger and more structurally sophisticated

The Regulatory Imperative for a Peptide Characterization CRO Deliverables Checklist A peptide characterization CRO deliverables checklist serves as a fundamental

Introduction: In peptide drug development, the quality of your analytical data is only as good as the reference standard anchoring

Introduction: Insulin analog characterization for generic ANDA is one of the most scientifically demanding challenges in the follow-on biologics space.

Introduction: Higher-order structure characterization of therapeutic peptides is no longer optional science — it is a regulatory and scientific imperative.

Introduction: The Critical Role of Peptide Aggregation Analysis in Biopharmaceutical Quality Peptide Aggregation Analysis is a critical regulatory and biophysical

Introduction: Why Cyclic Peptide Characterization Requires a Distinct Analytical Framework Characterizing cyclic peptides is far more than a straightforward extension